欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3862/002
药品名称Nistik 40 mg/5 mg/12,5 mg
活性成分
    • Amlodipine 5.0 mg
    • Hydrochlorothiazide 12.5 mg
    • Olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Menarini International O.L. S.A. 1, Avenue de la Gare L-1611 Luxembourg
参考成员国 - 产品名称Netherlands (NL)
Olmesartan/Amlodipine/HCT Daiichi Sankyo 40 mg/5 mg/12,5 mg filmomhulde tabletten
互认成员国 - 产品名称
    许可日期2017/07/05
    最近更新日期2025/01/16
    药物ATC编码
      • C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
    申请类型
    • TypeLevel1:Known Active Substance
    • TypeLevel2:Additional Strength/Form
    • TypeLevel3:Informed Consent Art 10c Dir 2001/83/EC
    • TypeLevel4:Chemical Substance
    • TypeLevel5:Prescription Only
    附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase